Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Int J Biol Sci ; 18(10): 4171-4186, 2022.
Article in English | MEDLINE | ID: mdl-35844805

ABSTRACT

CCDC65 is a member of the coiled-coil domain-containing protein family and was only reported in gastric cancer by our group. We first observed that it is downregulated in lung adenocarcinoma based on the TCGA database. Reduced CCDC65 protein was shown as an unfavorable factor promoting the clinical progression in lung adenocarcinoma. Subsequently, CCDC65-/- mice were found possibly dead of hydrocephalus. Compared with the CCDC65+/+ mice, the downregulation of CCDC65 in CCDC65+/- mice significantly increased the formation ability of lung cancer induced by urethane. In the subsequent investigation, we observed that CCDC65 functions as a tumor suppressor repressing cell proliferation in vitro and in vivo. Molecular mechanism showed that CCDC65 recruited E3 ubiquitin ligase FBXW7 to induce the ubiquitination degradation of c-Myc, an oncogenic transcription factor in tumors, and reduced c-Myc binding to ENO1 promoter, which suppressed the transcription of ENO1. In addition, CCDC65 also recruited FBXW7 to degrade ENO1 protein by ubiquitinated modulation. The downregulated ENO1 further reduced the phosphorylation activation of AKT1, which thus inactivated the cell cycle signal. Our data demonstrated that CCDC65 is a potential tumor suppressor by recruiting FBWX7 to suppress c-Myc/ENO1-induced cell cycle signal in lung adenocarcinoma.


Subject(s)
Adenocarcinoma of Lung , Glycoproteins , Lung Neoplasms , Animals , Mice , Adenocarcinoma of Lung/genetics , Cell Line, Tumor , Cell Proliferation , F-Box-WD Repeat-Containing Protein 7/genetics , Gene Knockout Techniques , Glycoproteins/metabolism , Lung Neoplasms/metabolism , Mice, Knockout , Ubiquitin-Protein Ligases/genetics , Ubiquitin-Protein Ligases/metabolism
3.
Acta Biochim Biophys Sin (Shanghai) ; 48(11): 1042-1049, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27733346

ABSTRACT

miR-203 is a tumor suppressor which participates in the pathogenesis of many tumors including lung adenocarcinoma. However, the role of miR-203 in suppressing chemotherapy resistance to cisplatin (cis-diamminedichloroplatinum; DDP) as well as its molecular mechanism is still to be determined in lung adenocarcinoma. In this study, we found that miR-203 decreased lung cancer cell migration and invasion, and that increased miR-203 expression sensitized lung adenocarcinoma cells to DDP in vitro Furthermore, ZEB2 was found to be a direct target of miR-203, which induces epithelial-mesenchymal transition (EMT) signal. Knock-down of ZEB2 significantly increased DDP chemosensitivity in lung adenocarcinoma. More interestingly, we also demonstrated that ZEB2 could directly bind to E-box of the miR-203 promoter and suppress its expression in lung adenocarcinoma. Our data reveal that miR-203 serves as a negative feedback by directly suppressing the upstream ZEB2 gene, which inhibits EMT signaling and reduces chemoresistance of DDP. Together, these results highlight a feedback loop between miR-203 and ZEB2, which participates in the pathogenesis of lung adenocarcinoma.


Subject(s)
Adenocarcinoma/pathology , Epithelial-Mesenchymal Transition , Homeodomain Proteins/metabolism , Lung Neoplasms/pathology , MicroRNAs/metabolism , Repressor Proteins/metabolism , Adenocarcinoma/metabolism , Cell Line, Tumor , Drug Resistance, Neoplasm , Gene Knockdown Techniques , Homeodomain Proteins/genetics , Humans , Lung Neoplasms/metabolism , MicroRNAs/genetics , Promoter Regions, Genetic , Repressor Proteins/genetics , Signal Transduction , Zinc Finger E-box Binding Homeobox 2
4.
Nat Commun ; 7: 11309, 2016 Apr 20.
Article in English | MEDLINE | ID: mdl-27095304

ABSTRACT

The biological role of miR-3188 has not yet been reported in the context of cancer. In this study, we observe that miR-3188 not only reduces cell-cycle transition and proliferation, but also significantly prolongs the survival time of tumour-bearing mice as well as sensitizes cells to 5-FU. Mechanistic analyses indicate that miR-3188 directly targets mTOR to inactivate p-PI3K/p-AKT/c-JUN and induces its own expression. This feedback loop further suppresses cell-cycle signalling through the p-PI3K/p-AKT/p-mTOR pathway. Interestingly, we also observe that miR-3188 direct targeting of mTOR is mediated by FOXO1 suppression of p-PI3K/p-AKT/c-JUN signalling. In clinical samples, reduced miR-3188 is an unfavourable factor and negatively correlates with mTOR and c-JUN levels but positively correlates with FOXO1 expression. Our studies demonstrate that as a tumour suppressor, miR-3188 directly targets mTOR to stimulate its own expression and participates in FOXO1-mediated repression of cell growth, tumorigenesis and NPC chemotherapy resistance.


Subject(s)
Forkhead Transcription Factors/genetics , Gene Expression Regulation, Neoplastic , JNK Mitogen-Activated Protein Kinases/genetics , MicroRNAs/genetics , Nasopharyngeal Neoplasms/genetics , Phosphatidylinositol 3-Kinases/genetics , TOR Serine-Threonine Kinases/genetics , Adult , Aged , Aged, 80 and over , Animals , Carcinoma , Cell Line, Tumor , Cell Transformation, Neoplastic/genetics , Cell Transformation, Neoplastic/metabolism , Cell Transformation, Neoplastic/pathology , Drug Resistance, Neoplasm/genetics , Feedback, Physiological , Female , Forkhead Box Protein O1 , Forkhead Transcription Factors/metabolism , Humans , JNK Mitogen-Activated Protein Kinases/metabolism , Male , Mice , MicroRNAs/metabolism , Middle Aged , Nasopharyngeal Carcinoma , Nasopharyngeal Neoplasms/diagnosis , Nasopharyngeal Neoplasms/metabolism , Nasopharyngeal Neoplasms/pathology , Neoplasm Staging , Neoplasm Transplantation , Phosphatidylinositol 3-Kinases/metabolism , Prognosis , Proto-Oncogene Proteins c-akt/genetics , Proto-Oncogene Proteins c-akt/metabolism , Signal Transduction , Survival Analysis , TOR Serine-Threonine Kinases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL